Harold I Feldman
Overview
Explore the profile of Harold I Feldman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
297
Citations
25620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zanoni F, Marasa M, Carlassara L, Verbitsky M, Khan A, Wang C, et al.
J Am Soc Nephrol
. 2025 Mar;
PMID: 40067412
Background: A family history of health conditions may reflect shared genetic and/or environmental risk. It is not well known to what extent family history impacts outcomes among patients with chronic...
2.
Yang W, Feldman H, Guo W
Stat Med
. 2024 Sep;
43(26):4913-4927.
PMID: 39248697
Clustering functional data aims to identify unique functional patterns in the entire domain, but this can be challenging due to phase variability that distorts the observed patterns. Curve registration can...
3.
Baudier R, Orlandi P, Yang W, Chen H, Bansal N, Blackston J, et al.
Kidney Med
. 2024 Aug;
6(8):100850.
PMID: 39131916
Rationale & Objective: Matrix metalloproteinase 2 (MMP-2) plays an important role in the development of fibrosis, the final common pathway of chronic kidney disease (CKD). This study aimed to assess...
4.
Schrauben S, Park D, Amaral S, Purcell A, Zhang S, Kearney M, et al.
Clin J Am Soc Nephrol
. 2024 Jul;
PMID: 38954482
No abstract available.
5.
Yeo W, Surapaneni A, Hasson D, Schmidt I, Sekula P, Kottgen A, et al.
J Am Soc Nephrol
. 2024 Jun;
PMID: 38844075
No abstract available.
6.
Schlosser P, Surapaneni A, Borisov O, Schmidt I, Zhou L, Anderson A, et al.
J Am Soc Nephrol
. 2024 Apr;
35(7):923-935.
PMID: 38640019
No abstract available.
7.
Wulczyn K, Shafi T, Anderson A, Rincon-Choles H, Clish C, Denburg M, et al.
Am J Kidney Dis
. 2024 Jan;
84(1):49-61.e1.
PMID: 38266973
Rationale & Objective: The toxins that contribute to uremic symptoms in patients with chronic kidney disease (CKD) are unknown. We sought to apply complementary statistical modeling approaches to data from...
8.
Leidner A, Cai X, Zelnick L, Lee J, Bansal N, Pasch A, et al.
Kidney Med
. 2023 Nov;
5(11):100723.
PMID: 37915961
Rationale & Objective: Heart failure (HF) is an important cause of morbidity and mortality among individuals with chronic kidney disease (CKD). A large body of evidence from preclinical and clinical...
9.
Canney M, Induruwage D, Tang M, Alencar De Pinho N, Er L, Zhao Y, et al.
Kidney Int Rep
. 2023 Oct;
8(10):2056-2067.
PMID: 37850014
Introduction: Despite recognized geographic and sex-based differences in hemoglobin in the general population, these factors are typically ignored in patients with chronic kidney disease (CKD) in whom a single therapeutic...
10.
Sharma K, Zhang G, Hansen J, Bjornstad P, Lee H, Menon R, et al.
J Clin Invest
. 2023 Aug;
133(20).
PMID: 37616058
Diabetic kidney disease (DKD) can lead to end-stage kidney disease (ESKD) and mortality; however, few mechanistic biomarkers are available for high-risk patients, especially those without macroalbuminuria. Urine from participants with...